Israel Biotech Fund I, L.P. Insider Trading

Name: Israel Biotech Fund I, L.P. insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Mar 6, 2024): Exercise/Conversion of 3,750,000 ADXS shares.

Get alerted when insiders trade ADXS

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Latest filings by Israel Biotech Fund I, L.P.

Filed	Company	Transaction	Shares	Value
Mar 6, 2024	Ayala Pharmaceuticals, Inc. (ADXS)	Exercise/Conversion	3,750,000	n/a
Feb 12, 2024	Ayala Pharmaceuticals, Inc. (ADXS)	Exercise/Conversion	1,926,221	$770.5K
Nov 21, 2023	Ayala Pharmaceuticals, Inc. (ADXS)	Purchase	2,812,500	n/a
Oct 31, 2023	Ayala Pharmaceuticals, Inc. (ADXS)	Purchase	658,858	n/a

Loading insider data...